| 28.10.2024 12:12 | OBD | Director / PDMR holdings and Total Voting Rights | RNS |
| 25.10.2024 07:00 | OBD | Prognostic Covid Severity Test Study Published | Reach |
| 22.10.2024 13:00 | OBD | CiRT Receives Clinical Approval from NYS CLEP | Reach |
| 15.10.2024 14:34 | OBD | Holding(s) in Company | RNS |
| 14.10.2024 15:34 | OBD | Oxford BioDynamics pledges to cut costs amid need to raise extra funds | Alliance |
| 14.10.2024 07:00 | OBD | Commercial update for FY24 | RNS |
| 07.10.2024 07:01 | OBD | Holding(s) in Company | RNS |
| 07.10.2024 07:00 | OBD | CIRRP Award Update | RNS |
| 11.09.2024 12:55 | OBD | Holding(s) in Company | RNS |
| 22.08.2024 16:59 | OBD | Holding(s) in Company | RNS |
| 22.08.2024 11:41 | OBD | Holding(s) in Company | RNS |
| 25.07.2024 07:00 | OBD | OBD pursuing EpiSwitch as companion diagnostics | Reach |
| 21.06.2024 15:42 | OBD | Grant of Options | RNS |
| 18.06.2024 16:58 | OBD | Oxford BioDynamics revenue up 49% in first half as test sales rise | Alliance |
| 18.06.2024 07:00 | OBD | Half-year Report | RNS |
| 11.06.2024 16:01 | TEP, TAM, OBD | UK earnings, trading statements calendar - next 7 days | Alliance |
| 06.06.2024 07:00 | OBD | OBD's PSE test to be used in NCI trial | Reach |
| 04.06.2024 10:28 | OBD | Oxford BioDynamics develops canine cancer test with 89% accuracy | Alliance |
| 04.06.2024 07:00 | OBD | OBD develops multi-cancer diagnostic test for dogs | Reach |
| 24.05.2024 07:00 | OBD | Notice of Results | RNS |
| 23.05.2024 21:08 | CEL, AET, PHAR | TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact | Alliance |
| 23.05.2024 07:00 | OBD | OBD partners with Goodbody Clinic on PSE test | RNS |
| 21.05.2024 14:06 | OBD | Oxford BioDynamics to provide tests to largest UK charitable hospital | Alliance |
| 21.05.2024 07:00 | OBD | OBD partners with The London Clinic for PSE & CiRT | RNS |
| 16.05.2024 20:09 | BBOX, MYI, NEXN | TRADING UPDATES: Bens Creek considers administration; Nexxen inks deal | Alliance |
| 16.05.2024 07:00 | OBD | OBD and King's College London collaborate on RA | Reach |
| 10.05.2024 13:11 | OBD | Holding(s) in Company | RNS |
| 25.04.2024 14:50 | OBD | Holding(s) in Company | RNS |
| 11.04.2024 14:36 | OBD | Holding(s) in Company | RNS |
| 10.04.2024 16:28 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 17:35 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 12:42 | OBD | Holding(s) in Company | RNS |
| 09.04.2024 11:56 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 16:52 | OBD | Holding(s) in Company | RNS |
| 05.04.2024 08:28 | OBD | Holding(s) in Company | RNS |
| 03.04.2024 14:31 | OBD | Oxford BioDynamics reaches "important milestone" with new laboratory | Alliance |
| 03.04.2024 12:57 | OBD | Results of GM | RNS |
| 03.04.2024 07:00 | OBD | OBD opens UK clinical testing facility | Reach |
| 27.03.2024 14:18 | OBD | Result of AGM | RNS |
| 14.03.2024 16:53 | OBD, AFC, ECR | TRADING UPDATES: FireAngel CFO resigns; ECR Minerals raises GBP585,000 | Alliance |
| 14.03.2024 07:00 | OBD | Results of Fundraising | RNS |
| 13.03.2024 20:49 | MACF, CORA, ELEG | EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal | Alliance |
| 13.03.2024 16:45 | OBD | PrimaryBid Offer | RNS |
| 13.03.2024 16:40 | OBD | Proposed Fundraising | RNS |
| 22.02.2024 14:30 | OBD | Annual Report & Accounts | RNS |
| 17.01.2024 10:50 | OBD | CORRECT: Oxford BioDynamics plunges as annual loss widens; revenue up | Alliance |
| 17.01.2024 10:43 | OBD | CORRECT: Oxford BioDynamics plunge as annual profit rises; revenue up | Alliance |
| 17.01.2024 10:35 | OBD | Oxford BioDynamics shares plunge as annual revenue widens; revenue up | Alliance |
| 17.01.2024 10:24 | FDEV, OBD, CRPR | AIM WINNERS & LOSERS: James Cropper falls on lower outlook | Alliance |
| 17.01.2024 07:00 | OBD | Preliminary Results and Notice of AGM | RNS |
| 21.12.2023 07:20 | OBD | Notice of Results | RNS |
| 13.11.2023 10:22 | OBD | Director/PDMR Shareholding | RNS |
| 08.11.2023 07:00 | OBD | OBD strengths commercial leadership | Reach |
| 07.11.2023 12:30 | OBD | Holding(s) in Company | RNS |
| 06.11.2023 17:04 | OBD | Holding(s) in Company | RNS |
| 03.11.2023 09:29 | OBD | Director/PDMR Shareholding | RNS |
| 23.10.2023 11:09 | OBD | PDMR Dealing / Grant of Share Options | RNS |
| 20.10.2023 10:32 | OBD | IN BRIEF: Oxford BioDynamics director sells over 700,000 shares | Alliance |
| 20.10.2023 09:45 | OBD | Director/PDMR Shareholding | RNS |
| 18.10.2023 10:25 | OBD | Oxford BioDynamics in deal with Bupa to expand blood test access | Alliance |
| 18.10.2023 07:00 | OBD | Bupa UK to cover EpiSwitch® CiRT for customers | RNS |
| 06.10.2023 17:44 | OBD | Director/PDMR Shareholding | RNS |
| 03.10.2023 16:37 | OBD | Holding(s) in Company | RNS |
| 03.10.2023 10:21 | OBD, AURR, RENX | AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection | Alliance |
| 03.10.2023 10:15 | OBD | Oxford BioDynamics issued insurance reimbursement code for EpiSwitch | Alliance |
| 03.10.2023 07:00 | OBD | OBD receives reimbursement code for PSE test | RNS |
| 26.09.2023 17:41 | OBD | Oxford BioDynamics soars as validates prostate test ahead of schedule | Alliance |
| 26.09.2023 07:00 | OBD | OBD launches 94% accurate PSE test in US and UK | RNS |
| 07.09.2023 10:18 | OBD | Holding(s) in Company | RNS |
| 01.09.2023 12:34 | OBD | Amendment: Director/PDMR Shareholding | RNS |
| 31.08.2023 16:02 | OBD | Holding(s) in Company | RNS |
| 25.08.2023 09:00 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 15:58 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 07:00 | OBD | Holding(s) in Company | RNS |
| 22.08.2023 07:00 | OBD | Holding(s) in Company | RNS |
